Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yeah, I'm surprised it's held up so well in this market, though lately the drift is decidedly downward.
I hope some news of substance- either an independent test or a product development PR happens soon. While the uplisting to the BB was nice, it's been a while since we heard anything beyond the name change.
sold out this week. lots of good ideas here but it's taking an awful long time to translate into revenue and earnings.
GLTA
Hi Hank,
Watching your action is better than NFL highlights!
Just wondering......
Do you trade Norweigian companies through a PK symbol or do you buy directly with a Europeon account?
Also, the 52 week on EGMS.OL would certainly seem to qualify for the basic "buy low sell high" premise of investing. Are you still holding or averaging down at these levels... or is the knife still too hot?
More importantly, whilst this 150,000 hit might be a one-off, how many shares can potentially hit the street in the next 6 months?
Nobody wants to sell me 10k for .51 each. Hmmm
This isn't the first time that CTUM has had a fantastic run on anticipation of news that didn't occur as hoped, and then fallen back sharply. Remember the FDA filing delay last year?
Approval is the price stabilizer here. Til then, the PPS is easily manipulated.
CTUM
This was my pick last year in the one-stock-winner-take-all contest. CTUM did 100% last year and has already done the same this year. The company is days or weeks away from FDA approval, has maintained a low O/S count and has attracted the services of some big-time specialists in the medical device field, all of whom have signed on-board for a % of future profits. The list of MMs, especially those with a Europeon link where CTUM already has approval for their tissue welding product, has also increased in the past few weeks, as has the daily volume.
The PPS spiked from the .70 range to 1.80 and has settled in around 1.50
This is in the rare category of BB stocks: the buy and hold variety.
There's some good DD from maddogs (and others) on the IH board:
http://investorshub.advfn.com/boards/board.asp?board_id=4496
Training, thanks for the 411. A couple of questions for you:
1. Are your PPS and buyout musings based solely on the potential of current LTC products awaiting FDA approval?
1. Do any of "the competitors" products in the pipeline aspire to the LTC claim of liver, lung and other organ connection, similar to repairing a "tear in a sponge"? This is surely the LTC edge, the difference between a solid, predictable company and a company with no limits.
TIA
could be late this year....or longer....
I'm not anticipating any news here soon. As much as I too would appreciate a PR with some $$$ signs in it, we very well might have to wait for Clarient to move ahead before that happens.
510k info from the FDA website shows that, with time allotted for holidays and seasonal slowdown, it's time for our turn with the FDA. If Frank hasn't needed to make any recent amendments to the application in the past 2-3 months, our wait in line should be over soon. Also encouraging is the big goose egg in the Number of Denials field.
Information on Premarket Approval Applications > PMA Final Decisions Rendered for December 2007
PMA Final Decisions Rendered for December 2007
Summary of PMA Originals & Supplements Approved
Originals: 2
Supplements: 63
Summary of PMA Originals Under Review
Total Under Review: 72
Total Active: 25
Total On Hold: 47
Number Greater Than 180 Days: 4
From the FDA site
Information on Premarket Approval Applications > PMA Final Decisions Rendered for December 2007
PMA Final Decisions Rendered for December 2007
Summary of PMA Supplements Under Review
Total Under Review: 409
Total Active: 227
Total On Hold: 182
Number Greater Than 180 Days: 13
Summary of All PMA Submissions Received
Originals: 3
Supplements: 99
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 63
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 126.4
FDA Time: 104.5 Days MFR Time: 21.9 Days
I can't imagine these heavy hitters would sign on to a start-up company in its early devlopment phase unless they were quite impressed by the potential.
At this PPS, what do you expect? A fully endorsed and approved line of tissue and organ connecting devices?
The only question with CTUM is, "do you think the company can do what it claims to be able to do?" No need to answer, because your answer means as little to me as the 6 month FDA approval speculation that was bandied about on this board when LTC was submitted. Similarly, I'm sure my opinion means very little to you.
Frank's opinion, on the other hand, carries a lot of weight with me. Many a OTC CEO makes massive claims about the future of their companies. Few back it up with stock purchases the way DR has. Fewer still are able to attract world-class experienced professionals to join their company in their seed phase. Frank saw the results of the LTC surgical procedures, either in person or as documented thousands of times. It's ludicrous to me to think that a man of his caliber in his field would accept a position with LTC if he wasn't absolutely convinced of its future.
As for the FDA, all we can do is wait, which is par for the course. Nothing I have read or seen over the past few months has changed my initial opinion. Certainly not the conjecture tossed around on message boards!
MLOBF.OB
Hong King cosmetics retailer that just released audited financials for 2007:
total OS: 1,237,134
net income: $ 1,292,561 (Canadian dollars)
The PPS actually dropped .10 since the earnings announcement on 14 Jan. 2008
Here's the link to the whole filing:
http://biz.yahoo.com/e/080114/mlobf.ob10ksb.html
This is either a truly hidden gem or a fine, fine display of smoke and mirrors.
I couldn't get a handle on the timeframe for the prostate test from the Clarient webcast. The speaker mentions the markers but not within a timeframe, as he does with breast cancer. He then goes on to use the expression "further out" followed by "2011".....That's longer away than I was hoping, but at least, at these prices, if the markers actually work as Clarient suggests, the upside here is distant but huge.
While I was out of town when the contest deadline passed and my prediction for approval wasn't accepted, my FDA prediction, while looking gloomy at the time, would certainly be most welcome now!
Posted by: rocketeer357
In reply to: gamood who wrote msg# 13495 Date:11/16/2007 1:28:39 AM
Post #of 14942
Feb 13 9:45 am
you and me both. LOL
Congrats Run and Value!!! An excellent pick in very rigorous competition. Well selected!
Do overseas companies that don't have PK symbols qualify?
Thanks for the board and a quick question:
If a pick is currently around the $1 mark but has spent months north of a dollar in the past year, will it be accepted if it's trading above, say .94 on the 11th?
TIA
I wouldn't mind having this job when the FDA envelope arrives in the mailbox! I wonder if watching the reaction of your employer opening a letter or email constitutes illegal insider information.
I emailed the company to let them know I'm interested in converting my CTUM shares if a LTC IPO happens. I don't see DR having a lot of free time for other business ventures once the LTC snowball gets rolling.
If 1/2 of what we dream for LTC comes to pass, there won't be enough hours in a week to coordinate the manufacture, training, PR and financials for LTC. The only thing better than 70% of something good is 100% of something good, unless I'm missing something here.
Your GGO.V post put me onto WEE.V, their partner in Rodney. Optimizing production from old wells is an industry that has both fattened and burned my wallet.
From their PRs, it would seem WEE has products that the O&G industry wants. Hopefully I can get an answer to some questions about the rates for these products, the size of the contracts and their durations.
GGO definitely fits my investment strategy of loading up at a low PPS, but I'm a bit concerned about the estimated production numbers in their report. Missing their 2007 estimates aside, assuming the company's rosy prediction of 600 BOeD from Rodney and Tilbury does indeed come to pass, where does the other 300 BOeD come from?
Looking at DXE and GGO, the current PPS and potential of both companies, why wouldn't you throw your dart at the possible elephant?
How sweet it is, LOL. Nothing beats free PR disseminated through such a wide range of popular media sources.
The current run up in the DSCI stock price looks to have only just begun and will hopefully continue upwards into earnings.
DSCI running to new highs on huge volume (relatively) and strong, recent insider buys.
Agreed. Many companies have the rights to amazing technology or patents to world- changing medical procedures. Realizing that potential in the form of revenue and income is much, much harder to achieve. But the stock is currently priced for ideas only; if they ever get the ball rolling with just a bit of news that points to a ROI on the patents, it's an easy 5 bagger from here before the dust even settles.
DualEx Energy DXE.V, DALFX.PK
Looks like insiders are taking advantage of the dip back to the .15 range
DualEx Energy International Inc. (DXE) As of December 19th, 2007
Filing Date Transaction Date
Insider Name
Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Dec 18/07 Dec 10/07 Nelson, John Direct Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.140
Dec 12/07 Dec 12/07 Morozoff, Lorne Andrew Direct Ownership Common Shares 10 - Acquisition in the public market 20,000 $0.150
Dec 12/07 Dec 12/07 Morozoff, Lorne Andrew Direct Ownership Common Shares 10 - Acquisition in the public market 80,000 $0.145
Dec 07/07 Dec 07/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 98,000 $0.150
Dec 07/07 Dec 07/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 36,000 $0.145
Dec 07/07 Dec 07/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 16,000 $0.140
Dec 06/07 Dec 06/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 225,000 $0.150
Dec 06/07 Dec 05/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.150
Dec 04/07 Dec 04/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 224,500 $0.150
Dec 04/07 Dec 04/07 Tompson, Kenneth, M Direct Ownership Common Shares 10 - Acquisition in the public market 23,000 $0.145
The insider purchases lately have reassured my decision to buy in at .65
I can't wait to see the #'s for the next 2 Qs. This is so far under the radar, but what's new there?
Hopefully the revenue #s we see in the next 3-6 months will be the beginnings of much repeat business.
I've been sitting on .149 shares sine the last run-up and decline. I recently added more as well.
I think news of the delay in the shipping of the rig from China is what pushed the PPS down. From a Co release:
"this newly built rig is now scheduled to arrive in Portugal in December, where it will first undertake the deepening of the Lapaducos-2 well. The rig will then be mobilized to the Aljubarrota-4 location."
At these prices, a multi-bagger is one successful well away.
Nothing to do but muse a bit while we wait for FDA....here goes:
1. FDA approval will lock in a PPS floor of $1, but we won't see $2 until there's some actual sales. The run from $2 to $65 will be much, much quicker than the run from .041 to $1.25
2. DR's genius is nowhere more apparent than how he hedged his Ukrainian bets by patenting 2 technologies, Landfill Gas and Live Tissue Connect. As a holder of .041 shares from 2005, I bought into CTUM on the then-stated premise that CO2 separators would generate the income needed to get LTC off the ground. Luckily, when Chastang didn't work out, DR still had the LTC card to play. And to date, he has played it masterfully.
That said, if/when FDA approval happens, LTC itself is enough of an entrepreneurial challenge for any CEO. Ergo,
3. I for one will seriously entertain the opportunity to exchange my CTUM shares for LTC shares in an IPO, especially if there's a sweetener for current CTUM shareholders.
I can find no sound reason why a CO2 separator isn't currently generating clean gas right now except for the obvious: it can't. Maybe it's the dirtiness of the landfill burn-off, maybe it's the cost of generation, maybe it's the irregularity in the methane content, but the positive PR benefits from a successful gas installation would blow away any expenses required for installation and maintenance.
Given the lack of success to date, I worry about throwing LTC money into the landfill, (as it were).
I'm still hopeful the FDA has some news this week. It seems like there's been plenty of time for Q&A between the FDA and Frank. Hopefully the FDA isn't considering whether LTC actually qualifies as an adaptation of an existing device....
Hank have you ever looked into DSCI? FDA approval of skin care products, Medicare codes for billing, the introduction of a new product line and some acquisitions. Recent bolstering of their sales staff as well.
4 different Dec 2007 purchases of 25000 shares or better by insiders.
This has been a slow play to develop but as the company forecasted, it looks like the pieces are falling into place heading into 2008.
They were break-even or earning .01 a share before the above developments. I bought at .63 and will add if there's any tax selling.
DXE.V has slid back to the .15 range. Hungary comes on-line in early 2008 and supposedly the rig which had been delayed has left China for Portugal.
Not much has changed since the last spate of insdier buying which doubled the share price....except the current Wall St meltdown...
2008 should be an excellent year
http://www.dualexen.com/operations/overview.html
Feb 13 9:45 am
TOPT took a nice size hit the other day with their earnings release. They're near a 52 week low but have recently shifted the biz model from oil tankers to a tanker/dry bulk mix.
Any opinion of management there?
10 Bagger,
Which FPSO compnaies are you holding in your current trading account?
Frankly Keith doesn't care what you think of his moves. Like him or hate him he's always been a virulent "my way or the highway" CEO. Forget about production and share #s. If you want that level of DD, find a reporting company that you think you can trust.
Cryptic PRs that are large on promise and lean on follow-up have been a large part of Keith's IR repetoire. Obviously the Street has had enough, as reflected in ther PPS.
If you liked it at .25 cents a share, I guess it's time to mortgage the house at today's prices...
BQI news out with independent assessment of tar sands reserves.....1+ billion barrels sounds pretty good until you discover management's estimate was off by 9 billion barrels.
CTUM up .10 to a buck on bigger volume as impending FDA news gets closer. The company's latest PR sure paints a very optimistic picture.
DR knows the Catch 22s of PRs. I for one bagged him out on this board for pre-announcing FDA submission "in early 2007" which, as we know, was an exaggeration of the true time frame. Long term holders also remember the DuPont Gas deal that really never came to fruition.
There's a lot at stake here- timing on news releases gets more complicted as the potential for the company's impact increases.
Any annoncements at this point will certainly help prospective partners and/or buyers define the value CTUM. I'm happy to let DR hold all the cards and play them as he sees fit; He's my only 22 bagger to date!!
Hank, are you still holding any of the dry bulk shippers or did you empty that basket?
After such a parabolic rise, PUT LEAPS are starting to look more attractive to me on EXM.
I'm surprised we held a buck as long as we did after the run-up to 90 days. IMO the PPS will drift down if we don't hear FDA results through the next few weeks.
I have no trouble with that: this isn't a $1 stock. It's a double digit stock or better (with approval and some time to generate business in the procedure). And I'm not surprised the FDA is taking more time. Maybe like the rest of us, they know that approval will mean a huge, huge change in tissue suturing, so they want to be 100% sure.